News & Events – Page 18 – Sumitovant

Select Company

March 18, 2019Urovant Sciences to Announce Topline Results from the EMPOWUR Phase 3 Study of Vibegron in Patients with Overactive Bladder
March 07, 2019Urovant Sciences to Present at the Cowen and Company 39th Annual Healthcare Conference
March 06, 2019Urovant Sciences Appoints James Robinson to its Board of Directors
March 05, 2019Myovant Sciences to Present at Upcoming Investor Conferences
February 22, 2019Urovant Sciences Enters into Flexible Agreement for up to $100 Million Debt Financing with Hercules Capital
February 21, 2019Enzyvant Appoints Industry Veteran Rachelle Jacques as Chief Executive Officer
February 13, 2019Urovant Sciences Reports Financial Results for the Third Fiscal Quarter Ended December 31, 2018
February 07, 2019Myovant Provides Corporate Updates and Reports Financial Results for Third Fiscal Quarter Ended December 31, 2018
February 06, 2019Urovant Sciences to Report 2018 Third Fiscal Quarter Financial Results
February 04, 2019Enzyvant to Highlight Investigational RVT-801 Program and Farber Disease Natural History Study at Upcoming WORLDSymposium™
« Previous 1 … 16 17 18 19 Next »